Loading clinical trials...
Loading clinical trials...
The primary aim of this study is to investigate the possibility to replace an erythrocyte based prime solution with a crystalloid based prime solution while maintaining metabolic function. Secondary a...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vastra Gotaland Region
NCT06961357 · Melanoma
NCT07076186 · Uterine Leiomyosarcoma
NCT07379138 · Melanoma
NCT06529822 · Muscle-Invasive Bladder Carcinoma, Gastroesophageal Adenocarcinoma, and more
NCT02390752 · Neurofibroma, Plexiform, Precursor Cell Lymphoblastic Leukemia-Lymphoma, and more
Sahlgrenska University Hospital
Gothenburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions